New transcriptome and clinical findings of platelet‐activating factor in chronic spontaneous urticaria: Pathogenic and treatment relevance
Authors:
- Evelyn AndradesEAEvelyn Andrades
- Miquel ClarósMCMiquel Clarós
- Lara NonellLNLara Nonell
- Mónica GonzálezMGMónica González
- Laia Curto‐BarredoLCLaia Curto‐Barredo
- Ramon GimenoRGRamon Gimeno
- Carlos BarrancoCBCarlos Barranco
- Ramon M. PujolRPRamon M. Pujol
- Iñaki IzquierdoIIIñaki Izquierdo
- Ana M. Giménez‐ArnauAGAna M. Giménez‐Arnau
- 4 August 2022
- journal article
- research article
- Published by Wiley in BioFactors
- Vol. 48 (6) , 1284-1294
Abstract
The objective of the study was to assess the pathogenic and treatment relevance of Platelet Activating factor (PAF) in chronic spontaneous urticaria (CSU). The expression and cellular location of PAF receptor (PAFR) and serum levels of PAF and PAF acetylhydrolase (PAF‐AH) in patients with moderate/severe CSU (n = 45) and healthy controls (HCs, n = 17) were studied. Skin samples from the active wheal (LS‐CSU, 13 samples for qPCR and 33 for immunohistochemistry) and non‐lesional skin (NLS‐CSU, 13 samples) of CSU patients and HCs (13 samples and 5 for immunohistochemistry) were analyzed. Serum PAF and PAF‐AH levels were measured by ELISA and compared between HC (10 samples) and CSU patients (25 samples) and, among them, between those refractory and non‐refractory to second‐generation H1‐antihistamines (sgAH). PAFR mRNA expression was significantly higher in LS‐CSU versus HCs (p = 0.014). PAFR positive staining in immunohistochemistry was mainly found in the epidermal basal layer in HCs, whereas it was broadly present along the epidermis in LS‐CSU samples. Endothelial cells showed PAFR expression exclusively in LS‐CSU and NLS‐CSU samples. PAFR expression was observed in the nerves of HC, LS‐CSU, and NLS‐CSU samples. Double PAFR/CD43 expression showed that T‐lymphocytes were the main cell type from the wheal inflammatory infiltrate expressing PAFR. A significantly lower PAF‐AH/PAF ratio was observed in sgAH non‐responders versus responders (6.1 vs. 12.6; p = 0.049). Our study confirms that PAF is a mediator of wheal pathogenesis in CSU. The significantly lower PAF‐AH/PAF ratio in sgAH non‐responders vs responders suggests that PAF could be a potential biomarker of sgAH refractoriness.Keywords
This publication has 32 references indexed in Scilit:
- Platelet‐activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulationAllergy, 2013
- Platelet-activating factor, histamine, and tryptase levels in human anaphylaxisJournal of Allergy and Clinical Immunology, 2013
- Mast cells are critically involved in serum-mediated vascular leakage in chronic urticaria beyond high-affinity IgE receptor stimulationAllergy, 2011
- Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report1Allergy, 2010
- EAACI/GA2LEN task force consensus report: the autologous serum skin test in urticariaAllergy, 2009
- Platelet-Activating Factor, PAF Acetylhydrolase, and Severe AnaphylaxisNew England Journal of Medicine, 2008
- Platelet-Activating Factor ReceptorThe Journal of Biochemistry, 2002
- Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthmaJournal of Clinical Investigation, 1999
- Expression of Platelet-Activating Factor Receptor mRNA in Human and Guinea Pig LungAmerican Journal of Respiratory Cell and Molecular Biology, 1994
- Association of Platelet-Activating Factor with Primary Acquired Cold UrticariaNew England Journal of Medicine, 1985